Healthcare Global Enterprises Limited (HCG:NSE) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
INR 496.67
(-6.43%)
Based on the Healthcare Global Enterprises Limited stock forecast from 3 analysts, the average analyst target price for Healthcare Global Enterprises Limited is INR 496.67 over the next 12 months. Healthcare Global Enterprises Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Healthcare Global Enterprises Limited is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Healthcare Global Enterprises Limited’s stock price was INR 530.80. Healthcare Global Enterprises Limited’s stock price has changed by +7.92% over the past week, +10.06% over the past month and +47.63% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for HCG:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
